文献速递主动脉疾病

二氧化碳血管造影在EVAR中的安全性与有效性:系统综述与荟萃分析

Safety and Effectiveness of Carbon Dioxide Angiography for Endovascular Aneurysm Repair: Systematic Review and Meta-Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-09-05

该系统综述与荟萃分析纳入8项研究共1699例患者,比较二氧化碳血管造影与碘对比剂在EVAR中的安全性和有效性。CO2组与ICM组急性肾损伤风险无统计学差异(RR 0.65,95%CI 0.27-1.56)。CO2血管造影在技术成功率和死亡率方面与ICM相当,但部分研究报道手术时间和辐射暴露增加。

要点

  • CO2血管造影与碘对比剂在EVAR中的急性肾损伤风险无统计学差异。
  • CO2组与ICM组死亡率无显著差异,技术成功率相当。
  • 部分研究显示CO2血管造影手术时间更长、辐射暴露更高。

核心结论

  • CO2血管造影在EVAR中显示与ICM相当的安全性和有效性。
  • ICM与CO2之间急性肾损伤风险降低无统计学差异。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane Library、Scopus和ISI数据库至2026年5月。
  • 纳入8项研究共1699例患者,其中581例接受CO2血管造影EVAR,1118例接受ICM。

主要发现

  • CO2血管造影组与ICM组急性肾损伤总体风险比为0.65(95%CI 0.27-1.56),I2=0%。
  • 部分研究中CO2血管造影与更长的手术时间和更高的辐射暴露相关。
  • CO2组术中内漏检出率相似或略高。
  • 两组死亡率无显著差异。

关键数值与推荐

  • 主要安全终点为急性肾损伤发生率,有效性依据技术成功率评估。
  • 急性肾损伤发生率采用随机效应荟萃分析合并,异质性来源通过荟萃回归探索。

临床怎么用

  • 对于肾功能不全或碘过敏患者,CO2血管造影可作为EVAR中ICM的替代选择。
  • 临床决策时应考虑CO2血管造影可能延长手术时间和增加辐射暴露。

局限性

  • 纳入研究数量较少(8项),样本量有限。
  • 部分研究报道手术时间和辐射暴露增加,提示操作相关负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aortic aneurysm repair (EVAR) traditionally relies on iodinated contrast medium (ICM), which can be problematic in patients with renal insufficiency or iodine allergy. Carbon dioxide (CO2) has emerged as a valuable alternative to mitigate these risks. This systematic review with meta-analysis aims to evaluate the safety and effectiveness of CO2 angiography in EVAR. METHODS: A literature search was conducted using PubMed, Cochrane Library, Scopus, and Institute for Scientific Information databases to identify studies published up to May 2026 that assessed CO2 angiography use in EVAR. The primary end point of safety was acute kidney injury (AKI) occurrence. Effectiveness was evaluated based on technical success rates. The incidence of AKI was pooled using a random-effects meta-analysis, with sources of heterogeneity explored via meta-regression. RESULTS: Eight studies involving 1,699 patients were included, with 581 undergoing EVAR with CO2 angiography and 1,118 receiving ICM. There was no statistical difference regarding AKI between the EVAR cohort assessed with CO2 angiography and the ICM angiography cohort, with an overall AKI risk ratio of 0.65 (95% confidence interval: 0.27-1.56) (I2 = 0%). CO2 angiography is associated with longer procedural times and higher radiation exposure in some studies. The intraoperative endoleak detection rate was similar or slightly higher in the CO2 group. No significant differences in mortality rates were observed between the groups. CONCLUSION: CO2 angiography shows comparable safety and effectiveness to ICM in EVAR procedures. However, risk reduction of AKI was not statistically different between ICM and CO2.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ferreira-Fernandes A, Dias L, Neiva-Sousa M, et al. Safety and Effectiveness of Carbon Dioxide Angiography for Endovascular Aneurysm Repair: Systematic Review and Meta-Analysis. Ann Vasc Surg. 2026. PMID: 42697324. doi:10.1016/j.avsg.2026.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。